Aytu BioPharma, Inc.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2021
Total Assets: $265.7M
Liabilities Breakdown FY2021
Total Liabilities: $128.1M
Asset Breakdown
Total Assets: $265.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $49.6M | 18.7% |
| Accounts Receivable | $28.2M | 10.6% |
| Inventory | $16.3M | 6.2% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $65.8M | 24.8% |
| Intangible Assets | $85.5M | 32.2% |
| Other Assets | $20.2M | 7.6% |
Liabilities Breakdown
Total Liabilities: $128.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $19.3M | 15.0% |
| Long-Term Debt | $180.0K | 0.1% |
| Other Liabilities | $108.7M | 84.8% |